Indian Drug Firms Tweak Global Plans Amid US Pricing Shake-Up

Indian generic drug firms are reconsidering their US export strategy after US President Donald Trump issued an executive order (EO) to cut prescription drug prices.

DCC Approves Proposal to Include GDP in Drugs Regulation

Drugs Consultative Committee (DCC) has also sanctioned a proposal to amend the Drugs Rules, 1945, with the inclusion of Good Distribution Practices (GDP) guidelines as a standalone schedule.

IMCD Boosts Pharma Portfolio with Trichem India Acquisition

IMCD, world leader in specialty chemicals and formulation and distribution of ingredients, has acquired 100 percent of Trichem's equity, an Indian supplier of pharmaceuticals based in Mumbai.

Indian Pharma Charts Clear Path to Meet Revised Schedule M Rules

As global pressure and expectations increase with the drug quality, Indian pharma has to become intolerant to non-compliance with Good Manufacturing Practice (GMP), stressed Mahantesh Wali, Regulatory Affairs Head at Maiva Pharma.

Aurobindo's Dyrupeg Biosimilar Secures UK Regulator's Approval

CuraTeQ Biologics, a wholly owned step-down subsidiary of Aurobindo Pharma, has received marketing authorization for its biosimilar Dyrupeg from the UK Medicines and Healthcare products Regulatory Agency (MHRA). The approval is an important...

Abbott, MSD Partner to Boost Diabetes Drug Distribution Nationwide

In a significant move that intended to improve access diabetes care in India, global pharmaceutical leaders Abbott and MSD Pharmaceuticals have entered into a strategic partnership

Revised Schedule M Puts Pressure on Small Drug Manufacturers

As the deadline has now passed, a large number of India’s small and mid-sized pharmaceutical manufacturers may be forced to shut down, as they have failed to provide required upgrade plans...

Pharmaceutical Exports Climb 7.4% in May, Continuing Upward Trend

India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US dollar 2.47 billion in May 2025 from US dollar 2.31 billion in the corresponding month last year, based on Ministry of Commerce and Industry released data.

Alembic Pharma Gets USFDA EIR for API Unit in Gujarat

Alembic Pharmaceuticals Ltd reported on Wednesday, June 18, that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing site, at Karakhadi, Gujarat...

India Supplies 70% of WHO Vaccines, 14% of US Generic Imports

The Smt. Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, provided a note to address at the Second Policymakers’ Forum, organized by the Indian Pharmacopoeia Commission

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.